Literature DB >> 5493292

Generalized solution to linear, to-compartment, open model for drug distribution.

K B Bischoff, R L Dedrick.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 5493292     DOI： 10.1016/0022-5193(70)90119-0

Source DB:  PubMed          Journal:  J Theor Biol        ISSN： 0022-5193            Impact factor:   2.691


× No keyword cloud information.
  11 in total

1.  Distribution of HEOD (dieldrin) in mammals: II. some applications of the preliminary model.

Authors:  F T Lindstrom; J W Gillett; S E Rodecap
Journal:  Arch Environ Contam Toxicol       Date:  1975       Impact factor: 2.804

2.  A PBPK model describing a xenobiotic with a short PK event scale.

Authors:  Xiaofeng Wang; Brian E Davies
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-07-09       Impact factor: 2.745

3.  COMPT, a time-sharing program for nonlinear regression analysis of compartmental models of drug distribution.

Authors:  M Pfeffer
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

4.  Distribution of HEOD (dieldrin) in mammals. I. Preliminary model.

Authors:  F T Lindstrom; J W Gillett; S E Rodecap
Journal:  Arch Environ Contam Toxicol       Date:  1974-03       Impact factor: 2.804

5.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

6.  Two-compartment model for plasma pharmacokinetics in individual blood vessels.

Authors:  L J Nugent; R K Jain
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

7.  Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.

Authors:  E L Francke; G B Appel; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

8.  Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.

Authors:  D A Spyker; R J Rugloski; R L Vann; W M O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

9.  Optimal design of perturbations for individual two-compartment pharmacokinetic analysis.

Authors:  Matthew S Shotwell; Minchun Zhou; William H Fissell
Journal:  J Biopharm Stat       Date:  2015-08-06       Impact factor: 1.051

10.  A mechanistic, model-based approach to safety assessment in clinical development.

Authors:  J Lippert; M Brosch; O von Kampen; M Meyer; H-U Siegmund; C Schafmayer; T Becker; B Laffert; L Görlitz; S Schreiber; P J Neuvonen; M Niemi; J Hampe; L Kuepfer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.